Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Iris Melanoma”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Ended earlyNCT00005841
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 15
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Testing effectiveness (Phase 2)Study completedNCT00089206
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Virginia 7
Not applicableStudy completedNCT00952939
What this trial is testing

Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
Case Comprehensive Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT00329641
What this trial is testing

Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+2 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT00072345
What this trial is testing

Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00738361
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery

Who this might be right for
Intraocular Melanoma
Ohio State University Comprehensive Cancer Center 4
Early research (Phase 1)Study completedNCT00705640
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Melanoma

Who this might be right for
Intraocular MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin)
Craig L Slingluff, Jr 45
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT02068586
What this trial is testing

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 210
Testing effectiveness (Phase 2)Study completedNCT00121225
What this trial is testing

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT00031733
What this trial is testing

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 60
Testing effectiveness (Phase 2)Study completedNCT00243061
What this trial is testing

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small Size+8 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00058279
What this trial is testing

Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00032045
What this trial is testing

Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00288041
What this trial is testing

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+3 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Load More Results